Evidence map›Paper›PMID 38343446›Full record

ArticleFrontiers in genetics2023

Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection.

Bang Liu, Ling-Ling Lu, Li Yu, Xuan Mei, Jia Liu, Jiao-Long Zheng, Xiao-Ling Zhou, Hai-Yan Lin, Xiu-Ling Zhu, Dong-Liang Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Bang Liu *Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
Ling-Ling Lu *Department of Infectious Disease, Fujian Medical University Union Hospital, Fuzhou, China.
Li Yu *Department of Digestive Diseases, 900th Hospital of Joint Logistics Support Force, Fuzhou, China.
Xuan MeiFuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
Jia LiuDepartment of Hepatobiliary Surgery, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Jiao-Long ZhengDepartment of Hepatobiliary Disease, 900th Hospital of Joint Logistics Support Force, Fuzhou, China.
Xiao-Ling ZhouDepartment of Hepatobiliary Disease, 900th Hospital of Joint Logistics Support Force, Fuzhou, China.
Hai-Yan LinDepartment of Hepatobiliary Disease, 900th Hospital of Joint Logistics Support Force, Fuzhou, China.
Xiu-Ling ZhuDepartment of Hepatobiliary Disease, 900th Hospital of Joint Logistics Support Force, Fuzhou, China.
Dong-Liang LiFuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
117th Hospital of People's Liberation Army · CNFujian Medical University · CNChinese PLA General Hospital · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

enrichment analysisHBV-related HCCimmune infiltrationprognosticTlk2

Identifiers

PMID38343446
PMCPMC10853388
OpenAlexW4391261540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.